Identification of PD-L1+status as a candidate predictive biomarker of response to talazoparib (TALA) in the phase 3 EMBRACA studyHope S. Rugo,Joanne L. Blum,A. Douglas Laird,Sara A. Hurvitz,Johannes Ettl,Lida A. Mina,Kyung-Hun Lee,Anthony Goncalves,Rinat Yerushalmi,Young-Hyuck Im,Miguel Martin,Louis Fehrenbacher,Henri H. Roche,Ying Chen,Silvana Lanzalone,Jijumon Chelliserry,Wolfgang Eiermann,Jennifer K. LittonCANCER RESEARCH(2022)引用 0|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要